1,734 results on '"Wesseling, Pieter"'
Search Results
202. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
203. Mutations in G Protein Encoding Genes and Chromosomal Alterations in Primary Leptomeningeal Melanocytic Neoplasms
204. Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
205. Histologic classification of gliomas
206. Erratum:Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)
207. Colocated discretization of the navier-stokes equations on highly non-smooth grids
208. The pathological diagnosis of diffuse gliomas: towards a smart synthesis of microscopic and molecular information in a multidisciplinary context
209. Incremental Gaussian Discriminant Analysis based on Graybill and Deal weighted combination of estimators for brain tumour diagnosis
210. Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors
211. Oligosarcomas, IDH-mutant are distinct and aggressive
212. Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
213. Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based study
214. A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
215. QOLP-05. HEALTH-RELATED QUALITY OF LIFE IN LOW-GRADE GLIOMA SURVIVORS 26 YEARS AFTER DIAGNOSIS
216. EPCO-17. METHYLATION ANALYSIS OF MATCHED PRIMARY AND RECURRENT IDHmt ASTROCYTOMA; AN UPDATE FROM THE GLIOMA LONGITUDINAL ANALYSIS NL (GLASS-NL) CONSORTIUM
217. PATH-23. OLIGOSARCOMA, IDH-MUTANT IS A DISTINCT AGGRESSIVE TYPE
218. EPCO-09. LONGITUDINAL ANALYSIS OF DIFFUSE GLIOMA REVEALS CELL STATE DYNAMICS AT RECURRENCE ASSOCIATED WITH CHANGES IN GENETICS AND THE MICROENVIRONMENT
219. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors
220. Embryonal tumor with multilayered rosettes (ETMR): signed, sealed, delivered …
221. Human pontine glioma cells can induce murine tumors
222. Successful third-line chemotherapy for an adult with recurrent medulloblastoma
223. Papillary Tumor of the Pineal Region: A Distinct Molecular Entity
224. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.
225. Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies.
226. fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries.
227. In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
228. A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern
229. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors
230. Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours
231. Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
232. Primary Melanocytic Tumors of the Central Nervous System: a Review with Focus on Molecular Aspects
233. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
234. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
235. Structure and Its Implications in Leopoldo Alas' La Regenta
236. Letter in Response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171
237. Primary intracranial germ-cell tumors in adults: a practical review
238. Immune Responses to Tumours in the CNS
239. Optical genome mapping identifies a germline retrotransposon insertion inSMARCB1in two siblings with atypical teratoid rhabdoid tumors
240. Abstract 3147: Stereotactic image-guided epigenome profiling reveals a neural stem cell evolutionary origin of diffuse gliomas
241. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
242. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study
243. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
244. Clinical characteristics of subsequent histologically confirmed meningiomas in long-term childhood cancer survivors: A Dutch LATER study
245. Spatial concordance of DNA methylation classification in diffuse glioma
246. Distribution of GOPC:ROS1 and other ROS1 fusions in glioma types
247. Spatial concordance of DNA methylation classification in diffuse glioma.
248. Sarcoma classification by DNA methylation profiling
249. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
250. Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.